
### [NCIT:C7164](http://purl.obolibrary.org/obo/NCIT_C7164)
**Label:** Classical Hodgkin Lymphoma

**Subclasses:** [NCIT:C8839](http://purl.obolibrary.org/obo/NCIT_C8839) (Stage I Nodular Sclerosis Classical Hodgkin Lymphoma), [NCIT:C6913](http://purl.obolibrary.org/obo/NCIT_C6913) (Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C8834](http://purl.obolibrary.org/obo/NCIT_C8834) (Stage I Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C136971](http://purl.obolibrary.org/obo/NCIT_C136971) (Recurrent Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C8835](http://purl.obolibrary.org/obo/NCIT_C8835) (Stage IV Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8832](http://purl.obolibrary.org/obo/NCIT_C8832) (Recurrent Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8833](http://purl.obolibrary.org/obo/NCIT_C8833) (Refractory Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C9127](http://purl.obolibrary.org/obo/NCIT_C9127) (Adult Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C7223](http://purl.obolibrary.org/obo/NCIT_C7223) (Adult Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C5067](http://purl.obolibrary.org/obo/NCIT_C5067) (Stage II Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C9125](http://purl.obolibrary.org/obo/NCIT_C9125) (Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8650](http://purl.obolibrary.org/obo/NCIT_C8650) (Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C8651](http://purl.obolibrary.org/obo/NCIT_C8651) (Stage IV Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C3583](http://purl.obolibrary.org/obo/NCIT_C3583) (Stage III Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C5064](http://purl.obolibrary.org/obo/NCIT_C5064) (Stage I Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C3582](http://purl.obolibrary.org/obo/NCIT_C3582) (Stage III Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8063](http://purl.obolibrary.org/obo/NCIT_C8063) (Childhood Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C8061](http://purl.obolibrary.org/obo/NCIT_C8061) (Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C69142](http://purl.obolibrary.org/obo/NCIT_C69142) (Childhood Classical Hodgkin Lymphoma), [NCIT:C8649](http://purl.obolibrary.org/obo/NCIT_C8649) (Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C5077](http://purl.obolibrary.org/obo/NCIT_C5077) (Stage II Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C7054](http://purl.obolibrary.org/obo/NCIT_C7054) (Childhood Lymphocyte-Rich Classical Hodgkin Lymphoma), [NCIT:C133592](http://purl.obolibrary.org/obo/NCIT_C133592) (Recurrent Classical Hodgkin Lymphoma), [NCIT:C5081](http://purl.obolibrary.org/obo/NCIT_C5081) (Stage II Nodular Sclerosis Classical Hodgkin Lymphoma), [NCIT:C9283](http://purl.obolibrary.org/obo/NCIT_C9283) (Lymphocyte-Depleted Classical Hodgkin Lymphoma), [NCIT:C69138](http://purl.obolibrary.org/obo/NCIT_C69138) (Adult Classical Hodgkin Lymphoma), [NCIT:C27807](http://purl.obolibrary.org/obo/NCIT_C27807) (Nodular Sclerosis Classical Hodgkin Lymphoma, Syncytial Variant), [NCIT:C133736](http://purl.obolibrary.org/obo/NCIT_C133736) (Refractory Classical Hodgkin Lymphoma), [NCIT:C3518](http://purl.obolibrary.org/obo/NCIT_C3518) (Nodular Sclerosis Classical Hodgkin Lymphoma), [NCIT:C3517](http://purl.obolibrary.org/obo/NCIT_C3517) (Mixed Cellularity Classical Hodgkin Lymphoma), [NCIT:C67171](http://purl.obolibrary.org/obo/NCIT_C67171) (Nodular Sclerosis Classical Hodgkin Lymphoma, Cellular Phase), 

**Class expressions from DL-Learner:**

- Thing 54.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39825](http://purl.obolibrary.org/obo/NCIT_C39825) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39820](http://purl.obolibrary.org/obo/NCIT_C39820) (Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39819](http://purl.obolibrary.org/obo/NCIT_C39819) (Infiltrating Bladder Urothelial Carcinoma, Nested Variant))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39818](http://purl.obolibrary.org/obo/NCIT_C39818) (Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39817](http://purl.obolibrary.org/obo/NCIT_C39817) (Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 36.83%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 36.83%


